Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AGIOS PHARMACEUTICALS, INC. | Director | Common stock | 15.5K | $756K | $48.84 | Jun 13, 2024 | Direct |
AGIOS PHARMACEUTICALS, INC. | Director | Restricted stock units | 2.12K | $104K | $48.84 | Jun 20, 2024 | Direct |
Carisma Therapeutics Inc. | Director | Stock Option (Right to Buy) | 38.7K | Jul 1, 2024 | Direct | ||
Editas Medicine, Inc. | Director | Stock Option (right to buy) | 25K | May 30, 2024 | Direct | ||
Magenta Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20K | Jun 28, 2022 | Direct | ||
AGIOS PHARMACEUTICALS, INC. | Director | Stock options (right to buy) | 11.8K | Jun 20, 2024 | Direct |